Literature DB >> 9230155

Absent right superior vena cava in visceroatrial situs solitus.

U Bartram1, S Van Praagh, J C Levine, M Hines, A S Bensky, R Van Praagh.   

Abstract

Absence of the right superior vena cava (SVC) in visceroatrial situs solitus is rare (0.07% to 0.13% of congenital cardiovascular malformations), and little is known about the type and frequency of additional heart defects and arrhythmias. We reviewed previous publications and present 9 new cases. Based on 121 known cases, we found that this anomaly is typically characterized by: (1) persistence of the left SVC draining into the right atrium by way of the coronary sinus, and (2) left-sided azygos vein draining into the left SVC. Less constant features were: (3) additional cardiovascular malformations (46%), and (4) rhythm abnormalities (36%) that usually appeared related to the complications of old age. Since absence of the right SVC is clinically silent, its status should be assessed echocardiographically prior to invasive medical or surgical procedures. This is important to avoid various management difficulties during the following procedures: (1) implantation of a transvenous pacemaker, (2) placement of a pulmonary artery catheter for intraoperative or intensive care unit monitoring without fluoroscopy, (3) systemic venous cannulation for extracorporeal membrane oxygenation, (4) systemic venous cannulation for cardiopulmonary bypass, (5) partial or total cavopulmonary anastomoses; and (6) orthotopic heart transplantation and endomyocardial biopsies.

Entities:  

Mesh:

Year:  1997        PMID: 9230155     DOI: 10.1016/s0002-9149(97)00314-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  32 in total

1.  Unusual systemic venous return with complete absence of the superior caval veins.

Authors:  T Krasemann; G Kehl; J Vogt; B Asfour
Journal:  Pediatr Cardiol       Date:  2002-10-29       Impact factor: 1.655

2.  Coronary artery bypass grafting with absent right superior vena cava in visceroatrial situs solitus.

Authors:  Kazuhiro Kurisu; Yoshie Ochiai; Hiroshi Kumeda; Satoshi Kimura; Kenichiro Tanaka; Ryuji Tominaga
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-04

3.  Unusual variation in upper-body venous anatomy found with cardiovascular MRI.

Authors:  Constantin B Marcu; Aernout M Beek; Albert C van Rossum
Journal:  CMAJ       Date:  2006-07-04       Impact factor: 8.262

4.  Absent left superior vena cava with persistent right superior vena cava in visceroatrial situs inversus.

Authors:  H Murayama; M Maeda; H Sakurai; T Watanabe
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

5.  Absent right and persistent left superior vena cava: fetal and neonatal echocardiographic diagnosis.

Authors:  G Favia Guarnieri; F Romano; L Clericò; G Balducci
Journal:  Pediatr Cardiol       Date:  2006 Sep-Oct       Impact factor: 1.655

6.  Challenging pacemaker implantation: persistent left superior vena cava with absent right superior vena cava.

Authors:  K Kraaier; J Poker; C von Birgelen; M F Scholten
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-02-11

7.  Bilateral absence of superior vena cava.

Authors:  Manish Bansal; James Strainic; Ravi Ashwath
Journal:  Pediatr Cardiol       Date:  2012-05-12       Impact factor: 1.655

8.  Congenital absence of right superior vena cava: a "stomach" within the heart.

Authors:  Ravindranath K Shankarappa; Ravi S Math; Praveen Jayan; Satish Karur; P S Seetharam Bhat; Manjunath Cholenahally Nanjappa
Journal:  Tex Heart Inst J       Date:  2012

9.  Isolated persistent left-sided superior vena cava, giant coronary sinus, atrial tachycardia and heart failure in a child.

Authors:  Nagaraja Moorthy; Aditya Kapoor; Sudeep Kumar
Journal:  Indian Heart J       Date:  2013-08-26

Review 10.  Partial absence of superior vena cava in an adult patient. Case report and literature review.

Authors:  D L Tarnoki; A D Tarnoki; K Nemeth; P Bata; V Berczi; K Karlinger
Journal:  Herz       Date:  2013-11       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.